In 2021, Germany was the leading country of origin for finished drugs imported into South Korea, with an import value of around 2.3 billion U.S. dollars. This was closely followed by the U.S. and Switzerland. That year, Germany was also the leading country of origin for all
Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Import value of pharmaceuticals into Finland 2013-2022
- Premium Statistic Pharmaceutical product imports in Chile 2014-2022
- Basic Statistic Italy: leading suppliers of imported pharmaceutical products 2017-2019
- Premium Statistic Italy: pharmaceutical marketing channels according to GPs
- Premium Statistic Italy: pharmaceutical marketing channels according to Medical Specialists 2017
- Premium Statistic Italy: market share of OTC products 2017, by segment
- Premium Statistic Italy: market share of respiratory diseases supplements 2017, by pathology
- Premium Statistic Market value of prescription drugs in Italy 2001-2022
- Premium Statistic Sales volume of the pharmaceutical market in Italy 2014-2022, by product
- Premium Statistic Gross pharmaceutical expenditure by the Italian NHS on prescription drugs 2012-2022
About the region
10
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Premium Statistic Revenue of the pharmaceutical company Bracco 2020, by geographical area
- Premium Statistic Foreign-to-Canadian generic drug price ratios by OECD country as of 2018
- Basic Statistic Allocation of R&D investments in pharmaceutical industry by function 2021
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2022-2028
- Basic Statistic Medicine spending share globally in 2007, 2022, and 2027, by country group
- Basic Statistic EBITDA of pharmaceutical company Recordati 2015-2022
- Premium Statistic Immunoglobulin consumption in select countries 2017
- Basic Statistic Top countries in global blood plasma market in 2017, by value
Selected statistics
7
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Pfizer's ad spending 2008-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Basic Statistic Cumulative price change of orphan drugs in the U.S. 2012-2014
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Visited pharmacy websites during the coronavirus lockdown in Spain January to March
- Premium Statistic Value of pharmaceutical product imports in Australia 2008-2019
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Premium Statistic Pharmaceutical imports in Colombia 2013-2022
- Premium Statistic Net pharmaceutical expenditure by the Italian NHS on prescription drugs 2012-2022
- Premium Statistic Yuhan's net income 2015-2021
- Premium Statistic Sales of top multinational pharmaceutical companies in China in Q1 2011
Related statistics
10
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue from prescription drugs Yuhan 2016-2022
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
Further related statistics
10
- Sanofi's total assets 2007-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
- Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Sales of Johnson & Johnson 2006-2022 by region
- Johnson & Johnson's number of employees 2004-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Merck & Co cash dividends declared 2006-2022
- Merck & Co total assets 2009-2022
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
- Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Sales of Johnson & Johnson 2006-2022 by region
- Johnson & Johnson's number of employees 2004-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Merck & Co cash dividends declared 2006-2022
- Merck & Co total assets 2009-2022
MFDS (South Korea). (December 29, 2022). Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars) [Graph]. In Statista. Retrieved September 27, 2023, from https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/
MFDS (South Korea). "Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars)." Chart. December 29, 2022. Statista. Accessed September 27, 2023. https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/
MFDS (South Korea). (2022). Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars). Statista. Statista Inc.. Accessed: September 27, 2023. https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/
MFDS (South Korea). "Leading Countries of Origin of Finished Drugs Imported into South Korea in 2021, by Import Value (in Million U.S. Dollars)." Statista, Statista Inc., 29 Dec 2022, https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/
MFDS (South Korea), Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars) Statista, https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/ (last visited September 27, 2023)
Leading countries of origin of finished drugs imported into South Korea in 2021, by import value (in million U.S. dollars) [Graph], MFDS (South Korea), December 29, 2022. [Online]. Available: https://www.statista.com/statistics/1296863/south-korea-leading-origins-for-finished-drug-imports-by-value/